0001104659-19-065555.txt : 20191119
0001104659-19-065555.hdr.sgml : 20191119
20191119190101
ACCESSION NUMBER: 0001104659-19-065555
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191119
FILED AS OF DATE: 20191119
DATE AS OF CHANGE: 20191119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weyer Christian
CENTRAL INDEX KEY: 0001493811
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35668
FILM NUMBER: 191232685
MAIL ADDRESS:
STREET 1: 9360 TOWNE CENTRE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001270073
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223868459
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 HUDSON YARDS, 37TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 646-747-1000
MAIL ADDRESS:
STREET 1: 10 HUDSON YARDS, 37TH FLOOR
CITY: New York
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20031113
4
1
tm1923434d2_4.xml
OWNERSHIP DOCUMENT
X0306
4
2019-11-19
0
0001270073
INTERCEPT PHARMACEUTICALS, INC.
ICPT
0001493811
Weyer Christian
C/O INTERCEPT PHARMACEUTICALS, INC.
10 HUDSON YARDS, FLOOR 37
NEW YORK
NY
10001
0
1
0
0
EVP, Research & Development
Common Stock
2019-11-19
4
S
0
1550
85.00
D
15759
D
This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
/s/ Mark Pruzanski, as attorney-in-fact
2019-11-19